Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-15

FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sertraline Hydrochloride from XLCare Pharmaceuticals, Inc., authorizing the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline hydrochloride (sertraline hydrochloride)

Snippet

SUPPL AP for SERTRALINE HYDROCHLORIDE (SERTRALINE HYDROCHLORIDE)